• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统腹膜透析液对中性粒细胞超氧化物生成的抑制作用。

Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution.

作者信息

Ing B L, Gupta D K, Nawab Z M, Zhou F Q, Rahman M A, Daugirdas J T

机构信息

Department of Medicine, Veterans Administration Hospital, Hines, Illinois.

出版信息

Int J Artif Organs. 1988 Sep;11(5):351-4.

PMID:2847987
Abstract

The pH of conventional peritoneal dialysis solution is normally in the range of 5.0 to 5.5, because acid has been added during the manufacturing process to prevent caramelization of dextrose during sterilization. We studied the effects of normalizing the pH of conventional peritoneal dialysis solution on superoxide production by normal human neutrophils. At a pH of 6.0, superoxide generation was 4.07 +/- 2.56 (SD) nanomoles per million cells. With normalization of pH to 7.4, superoxide production was 19.3 +/- 7.3 (p less than 0.001). The results suggest that the unphysiologic acidity of conventional peritoneal dialysis solution has deleterious consequences on neutrophil superoxide formation.

摘要

传统腹膜透析液的pH值通常在5.0至5.5范围内,因为在制造过程中添加了酸以防止葡萄糖在灭菌过程中焦糖化。我们研究了将传统腹膜透析液的pH值正常化对正常人中性粒细胞产生超氧化物的影响。在pH值为6.0时,超氧化物生成量为每百万细胞4.07±2.56(标准差)纳摩尔。随着pH值正常化为7.4,超氧化物生成量为19.3±7.3(p<0.001)。结果表明,传统腹膜透析液的非生理酸度对中性粒细胞超氧化物形成有有害影响。

相似文献

1
Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution.传统腹膜透析液对中性粒细胞超氧化物生成的抑制作用。
Int J Artif Organs. 1988 Sep;11(5):351-4.
2
Superoxide generation by neutrophils after exposure to a conventional peritoneal dialysis solution for different time periods.中性粒细胞在暴露于传统腹膜透析液不同时间段后产生超氧化物的情况。
Int J Artif Organs. 1990 Apr;13(4):228-30.
3
Failure of neutrophils to recover their ability to produce superoxide after stunning by a conventional, acidic, lactate-based peritoneal dialysis solution.在用传统的、酸性的、基于乳酸盐的腹膜透析液冲击后,中性粒细胞无法恢复其产生超氧化物的能力。
Int J Artif Organs. 1994 Apr;17(4):191-4.
4
Effects of a pH 7.4, lactate-based and a pH 7.4, bicarbonate-based peritoneal dialysis solutions on neutrophil superoxide generation.pH 7.4的乳酸盐基腹膜透析液和pH 7.4的碳酸氢盐基腹膜透析液对中性粒细胞超氧化物生成的影响。
Int J Artif Organs. 1996 Dec;19(12):700-3.
5
Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils.含碳酸氢盐与含乳酸盐的腹膜透析液对人中性粒细胞产生超氧化物的影响。
Artif Organs. 1989 Dec;13(6):495-7. doi: 10.1111/j.1525-1594.1989.tb01568.x.
6
Effects of hypertonic peritoneal dialysis solutions on neutrophil superoxide production.高渗腹膜透析液对中性粒细胞超氧化物生成的影响。
Artif Organs. 1990 Dec;14(6):410-2. doi: 10.1111/j.1525-1594.1990.tb02995.x.
7
Neutrophil intracellular pH after exposure of neutrophils to a euhydric, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart.中性粒细胞暴露于等渗的、基于乳酸盐的腹膜透析液及其等渗的、基于碳酸氢盐的对应物后细胞内的pH值。
Int J Artif Organs. 1995 Feb;18(2):69-72.
8
Pyruvate preserves neutrophilic superoxide production in acidic, high glucose-enriched peritoneal dialysis solutions.丙酮酸可维持酸性、高糖腹膜透析液中嗜中性粒细胞超氧化物的产生。
Artif Organs. 2003 Mar;27(3):276-81. doi: 10.1046/j.1525-1594.2003.69962.x.
9
Improved cytosolic free calcium mobilization and superoxide production in bicarbonate-based peritoneal dialysis solution.基于碳酸氢盐的腹膜透析液中细胞溶质游离钙动员和超氧化物生成的改善。
Nephrol Dial Transplant. 1997 May;12(5):973-7. doi: 10.1093/ndt/12.5.973.
10
A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function.一种采用双室系统提供的新型乳酸基、无增塑剂、中性腹膜透析液:对外周白细胞功能的影响
Nephron. 2000 Sep;86(1):62-9. doi: 10.1159/000045714.

引用本文的文献

1
A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy.一种适用于日本患者的新型腹膜透析液:安全性和有效性的随机非劣效性临床试验
Clin Exp Nephrol. 2017 Oct;21(5):895-907. doi: 10.1007/s10157-016-1346-9. Epub 2016 Oct 25.